Rocket, Labs

Rocket Lab's Iridium Vote Nears as Neutron Tests Advance and Electron Hits a 25-Day Sprint

Published on 09/22/2026 at 14:51 | Editorial boerse-global.de

Iridium shareholders vote Thursday on Rocket Lab's $8.1B enterprise-value takeover, with Neutron testing underway and a record $2.36B backlog.

Rocket Lab-Iridium Vote Set as Neutron Advances and Backlog Hits $2.36B
Rocket Lab's Iridium Vote Nears as Neutron Tests Advance and Electron Hits a 25-Day Sprint Illustration mit AI erstellt.

Rocket Lab's transformation from a pure launch provider into a vertically integrated space company is entering its decisive phase, with Iridium Communications shareholders set to vote Thursday on a takeover that would fold satellite communications into a business already spanning rockets and spacecraft manufacturing.

CEO Peter Beck fleshed out the strategic logic behind the combination, which would place launch vehicles, spacecraft production and global satellite connectivity under one roof. He sized the launch market at $10 billion to $20 billion and spacecraft at $20 billion to $30 billion, but pointed to downstream services and applications as the substantially larger revenue opportunity.

A $8.1 Billion Deal, Fully Financed

The transaction values Iridium at an equity value of $6.0 billion and an enterprise value of $8.1 billion. Under the terms on the table, Iridium shareholders would receive $27 per share in cash plus a variable slice of Rocket Lab stock, with existing Iridium holders expected to own roughly 5 percent of the combined company once the deal closes — a target set for mid-2027, subject to regulatory approvals.

The cash component is already funded. Rocket Lab placed 29.3 million shares through an at-the-market program, raising $1.944 billion, and completed the raise on September 15. That same day, the company terminated a $3.6 billion secured bridge facility, replacing short-term financing with a more durable structure and easing interest-rate exposure ahead of closing. Iridium, for its part, amended an existing $1.775 billion credit facility to accommodate the change of control, with a guarantee provided by Rocket Lab USA.

For investors, the question has shifted from how the money would be raised to whether the combined company's free cash flow can reliably service the assumed liabilities.

Should investors sell immediately? Or is it worth buying Rocket Lab?

Neutron Progress and a Record Backlog

On the development front, Rocket Lab cleared functional testing of the Neutron rocket's folding payload fairing. Engineers also installed a ten-meter test stand at the company's launch site in the US state of Virginia, where the second stage's engine modules will be tested on site. The medium-lift, reusable Neutron remains one of two catalysts Cantor Fitzgerald's Andres Sheppard flagged as central to the equity story; he reiterated an "Overweight" rating with a $122 price target. The other is completion of the Iridium acquisition. Sheppard also highlighted the established launch infrastructure, a growing book of government contracts and the push into larger payloads as competitive advantages.

Raymond James initiated coverage on September 11 with an "Outperform" rating and an $80 price target.

Meanwhile, the existing business is running at full tilt. Rocket Lab's 96th overall mission — the "Owl By The Dozen" flight — carried the twelfth StriX radar satellite for Japan's Synspective into a 572-kilometer orbit, marking the company's 17th launch this year. The Synspective partnership has maintained a 100 percent success rate, with 15 further missions contracted through the end of the decade. Total backlog stands at a record $2.36 billion. A 97th launch is already in preparation, representing the fourth Electron mission in 25 days.

Guidance and the Dilution Trade-Off

For the third quarter of 2026, Rocket Lab guided revenue to between $250 million and $265 million, with a GAAP gross margin of 29 to 31 percent and an adjusted gross margin of 35 to 37 percent. How efficiently the two halves of the business mesh will be judged against that adjusted figure.

The $1.944 billion capital raise has noticeably expanded the share count, and that dilution tempers per-share upside if the hoped-for synergies fall short. Regulatory risk also hangs over the timeline: competition and telecommunications authorities must sign off before the targeted mid-2027 close, and delays or conditions could inflate integration costs. Orbital operations carry their own hazards — any Electron failure would rattle customers and dent launch-segment revenue. The amended Iridium credit facility also ties up liquidity through parent-company guarantees, leaving limited room for unexpected cost increases should adjusted gross margins settle at the low end of the 35 to 37 percent range.

In today's trading, the stock climbed 2.0 percent to EUR 62.10, moving back above its 50-day moving average of EUR 60.09 and extending its recent recovery. Holding that level keeps confidence in the strategic realignment intact and leaves room for further valuation upside on Iridium's revenue streams; a sustained break below it would likely hand the initiative to concerns about dilution and debt load.

The next hard catalyst is the final third-quarter 2026 report, which will show whether revenue lands within the $250 million to $265 million range and whether profitability holds. Interim steps in the regulatory review of the Iridium takeover should shape the stock's medium-term direction in the meantime.

Ad

Rocket Lab Stock: New Analysis - 22 September

Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Rocket Lab analysis...

Disclaimer...

en | US7731211089 | ROCKET | boerse | 70155841 |